The Future of Immunotherapy-Based Combination Therapy in Metastatic Renal Cell Carcinoma

In the past two decades, there has been a significant improvement in the understanding of the molecular pathogenesis of Renal Cell Carcinoma (RCC). These insights in the biological pathways have resulted in the development of multiple agents targeting vascular endothelial growth factor (VEGF), as we...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rohan Garje, Josiah An, Austin Greco, Raju Kumar Vaddepally, Yousef Zakharia
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2020-01-01
Colecção:Cancers
Assuntos:
renal cell carcinoma
checkpoint inhibitors
vegf inhibitors
mtor inhibitors
Acesso em linha:https://www.mdpi.com/2072-6694/12/1/143
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados